BioXcel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.32 | $-0.48 | 33.3 % |
Jun 2024 | 2024-08-06 | $-0.21 | $-0.71 | 70.4 % |
Mar 2024 | 2024-05-09 | $-0.87 | $-0.70 | -24.3 % |
Dec 2023 | 2024-03-12 | $-0.76 | $-0.91 | 16.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $214.00K | $1.33M | -83.9 % |
Jun 2024 | 2024-08-06 | $1.10M | $680.00K | 62.4 % |
Mar 2024 | 2024-05-09 | $582.00K | $460.00K | 26.5 % |
Dec 2023 | 2024-03-12 | $376.00K | $710.00K | -47.0 % |
BioXcel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
BioXcel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.32, which beat the estimate of $-0.48.
BioXcel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.